Perlmutter Cancer Center at NYU Langone Arena Oncology

North New Hyde Park, NY

Sorting 1 by

Accepting patients

CA088-1005

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/​or Refractory Multiple Myeloma
Learn more
  • CAR T Cell
  • GPRC5D
  • Phase 1
  • Has results